International Clinical Trial: A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07537231) titled 'A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants' on April 7.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Health Services Research. Masking: None (Open Label).

Primary Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Condition: Healthy Postmenopausal Women Absorption Metabolism Excretion

Intervention: Drug: [14C]GS1-144

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: April 1, 2026

Target Sample Size: 8

Co...